147
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer

ORCID Icon, , , , , , , , ORCID Icon, & ORCID Icon show all
Pages 1039-1049 | Published online: 19 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bertha Alejandra Martinez-Cannon, Regina Barragan-Carrillo & Cynthia Villarreal-Garza. (2021) Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better. Breast Cancer: Targets and Therapy 13, pages 641-650.
Read now

Articles from other publishers (8)

Kate E. Dibble, Richard N. Baumgartner, Stephanie D. Boone, Kathy B. Baumgartner & Avonne E. Connor. (2023) Treatment-related side effects among Hispanic and non-Hispanic white long-term breast cancer survivors by tamoxifen use and duration. Breast Cancer Research and Treatment 199:1, pages 155-172.
Crossref
Jie Shen, Jing Yan, Juan Du, Xiaoqin Li, Jia Wei, Qin Liu, Hongmei Yong, Xiaolu Wang, Xiaofeng Chang, Zhou Ding, Wu Sun, Chenxi Liu, Sihui Zhu, Jingyi Guo, Huajun Li, Ying Liu, Wulou Zhang, Zonghang Liu, Rutian Li & Baorui Liu. (2023) Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors. Frontiers in Immunology 14.
Crossref
Deepa S Mandlik, Satish K Mandlik & Heena B Choudhary. (2023) Immunotherapy for hepatocellular carcinoma: Current status and future perspectives. World Journal of Gastroenterology 29:6, pages 1054-1075.
Crossref
Oluwatosin A. Ayeni, Shingirai Chiwambutsa, Wenlong Carl Chen, Nyasha Kapungu, Comfort Kanji, Roslyn Thelingwani, Nivashni Murugan, Rofhiwa Mathiba, Boitumelo Phakathi, Sarah Nietz, Duvern Ramiah, Daniel S. O’Neil, Judith S. Jacobson, Paul Ruff, Herbert Cubasch, Tobias Chirwa, Maureen Joffe, Collen Masimirembwa & Alfred I. Neugut. (2022) The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa. Breast Cancer Research and Treatment 197:3, pages 647-659.
Crossref
Seongwoo Yang, Seong Won Park, Soong June Bae, Sung Gwe Ahn, Joon Jeong & Kyounghoon Park. (2023) Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review. Journal of Breast Cancer 26.
Crossref
Xingyu Chen, Lixiang Feng, Yujing Huang, Yi Wu & Na Xie. (2022) Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer. Cancers 15:1, pages 104.
Crossref
Lei Zhao, Nijia Chang, Lei Shi, Fengyi Li, Fanglin Meng, Xiaohui Xie, Zhe Xu & Fusheng Wang. (2022) Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study. Heliyon 8:6, pages e09538.
Crossref
Ri-Lan Bai, Nan-Ya Wang, Ling-Ling Zhao, Yong-Fei Zhang & Jiu-Wei Cui. (2022) Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma. Hepatobiliary & Pancreatic Diseases International 21:1, pages 10-24.
Crossref